2015
DOI: 10.14440/bladder.2015.42
|View full text |Cite
|
Sign up to set email alerts
|

Nocturia: an overview of evaluation and treatment

Abstract: OBJECTIVE: Nocturia is a highly prevalent and bothersome condition. It is associated with multiple medical comorbidities and an increased mortality. Recent investigations have improved understanding of nocturia and its evaluation and treatment. This paper aims to review the classification, etiology, associated medical conditions, evaluation, and treatment of nocturia. MATERIALS AND METHODS:A review was conducted surveying published clinical trials, meta-analyses and current clinical practice guidelines on noct… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2016
2016
2019
2019

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 32 publications
0
2
0
Order By: Relevance
“…A thorough assessment of nocturia and its possible causes is crucial before treatment initiation (Table ; also see Checklist available as online material) . The evaluation of a patient should begin with taking a thorough history to assess, understand and discriminate LUTS in general and nocturia in particular.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…A thorough assessment of nocturia and its possible causes is crucial before treatment initiation (Table ; also see Checklist available as online material) . The evaluation of a patient should begin with taking a thorough history to assess, understand and discriminate LUTS in general and nocturia in particular.…”
Section: Resultsmentioning
confidence: 99%
“…The use of antimuscarinics or β 3 ‐agonists (mirabegron) for overactive bladder management and α 1 ‐blockers, 5α‐reductase inhibitors with or without α 1 ‐blockers, PDE5i or plant extracts for male LUTS/bladder outlet obstruction has been shown to significantly reduce nocturnal voiding frequency in populations where the indicated condition is shown to be present, albeit to limited clinical effects of approximately −0.2 episodes per night on average compared to placebo . Emerging evidence has also indicated a role for onabotulinumtoxinA injections in reducing night‐time nocturia in patients with overactive bladder without nocturnal polyuria …”
Section: Resultsmentioning
confidence: 99%